This inventor holds 1 USPTO granted patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Work of Inventor Koichi Kiyota
Introduction
Koichi Kiyota, an accomplished inventor based in Tochigi, Japan, has made significant contributions to the field of pharmaceuticals. His innovative mind has led to the development of a unique method for producing valuable pharmaceutical intermediates, showcasing the importance of chemistry in drug development.
Latest Patents
Kiyota holds a patent for a method titled "Method for producing 3,4-disubstituted pyrrolidine derivative." This invention presents an inexpensive and industrially advantageous method for creating an optically active form of anti-(3S,4R)-3-alkylcarbamoyl-4-hydroxypyrrolidine or its enantiomer. These compounds serve as key intermediates in producing high-quality optically active forms of (3R,4S)-3-alkylaminomethyl-4-fluoropyrrolidine, which is crucial in pharmaceutical applications. The invention utilizes asymmetric hydrogenation with an optically active catalyst of a 4-oxopyrrolidine-3-carboxamide derivative, representing a significant advancement in synthetic organic chemistry.
Career Highlights
Koichi Kiyota's career is notably marked by his role at Kyorin Pharmaceutical Co., Ltd. His expertise in chemical synthesis has been vital in advancing the pharmaceutical company's research and development efforts. With one registered patent, he has demonstrated his ability to merge scientific theory with practical applications in drug production.
Collaborations
Throughout his career, Kiyota has collaborated with notable colleagues, including Ichiro Araya and Muneki Nagao. These partnerships highlight the collaborative nature of research in pharmaceuticals, where multidisciplinary teams work together to innovate and solve complex problems in drug design and synthesis.
Conclusion
In conclusion, Koichi Kiyota stands out as a key inventor in the pharmaceutical industry, particularly through his significant patent related to the production of pyrrolidine derivatives. His contributions not only demonstrate his innovative capabilities but also reflect the critical role of inventors in developing new methods that can lead to improved pharmaceutical products. Kiyota's work exemplifies how creativity and scientific inquiry can lead to transformative advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
